Crossmark

A multitier virtual screening of antagonists targeting PD-1/PD-L1 interface for the management of triple-negative breast cancer

Published Online: 2023-09-30

Authors

Krishnamoorthy, HemaNandini Rajendran

Karuppasamy, Ramanathan https://orcid.org/0000-0002-1613-0729
License Information

Text and Data Mining valid from 2023-09-30

Version of Record valid from 2023-09-30
More Information

Article History

Received: 21 July 2023

Accepted: 4 September 2023

First Online: 30 September 2023

Declarations

:

: The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Document is current